Impact of Proposed Cuts to NIH Budget:

More Than Just About Cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

If enacted, the proposed budget reduction of $5.8 billion to the National Institutes of Health will slow research, deprive patients afflicted with cancer of hope, and deliver a devastating blow to our science workforce and the Commonwealth of Pennsylvania. This proposed reduction directly counters the wisdom of the U.S. Congress, who less than a year ago overwhelmingly passed the 21st Century Cures Act.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more
The intersection of diabetes, obesity and cancer represents an important and underappreciated challenge in medicine. Apart from smoking, overweight is now the leading modifiable risk factor for cancer. With the global epidemic of overweight and diabetes driving cancer incidence across multiple organ sites, understanding the metabolic underpinnings of this relationship has never been more critical.
Karen E. Knudsen, PhD
Director, Sidney Kimmel Cancer Center, Thomas Jefferson University
Chi Van Dang, MD, PhD
Director, Abramson Cancer Center, University of Pennsylvania
Richard I. Fisher, MD
Director, Fox Chase Cancer Center, Temple University Health System
Edward Chu, MD
Interim director, University of Pittsburgh Cancer Institute
Dario Altieri, MD
Director, Wistar Institute Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login